Treatment of rectal chlamydia infection in gay and bisexual men

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Rectal chlamydia is very common in gay men; it can exist for long periods without symptoms leading to ongoing transmission. There are two choices for antibiotic treatment: azithromycin and doxycycline, but there is uncertainty about which is more effective. This research will determine which treatment is best and what the economic implications are. The findings will update treatment guidelines and ensure that the most effective treatment is used to prevent ongoing transmission.

Funded Activity Details

Start Date: 01-01-2017

End Date: 01-01-2019

Funding Scheme: Postgraduate Scholarships

Funding Amount: $64,713.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Epidemiology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

chlamydial diseases | primary care | sexual behaviour | sexually-transmitted infections (STI) | treatment efficacy